Anti-HIV drug tenofovir is safe to take during pregnancy
May 15, 2012
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, supporting the use of this drug during pregnancy, according to a study by a team of international researchers published in this week's PLoS Medicine.
Read more
Reading level: College
EurekAlert!, the online, global news service operated by AAAS, the science society




